Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption
Despite many antihypertensive options, uncontrolled hypertension remains pervasive. Aldosterone synthase inhibitors show robust blood pressure reductions and have the potential to reshape hypertension treatment, though cost and access may impact broad adoption.
Authors
- Luke J. Laffin (ORCID: https://orcid.org/0000-0002-3262-792X)
- Steven E. Nissen
Institutions
- Cleveland Clinic (US)
- Cleveland Foundation (US)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1371/journal.pmed.1004900
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00